Call Now

EU MDR Clinical Evaluation Services for Medical Devices

Cert3Global provides expert EU MDR Clinical Evaluation Services to help medical device manufacturers demonstrate safety, performance, and clinical benefits in accordance with MDR (EU) 2017/745. Our team supports the planning, evaluation, and documentation of clinical evidence required for CE marking and ongoing regulatory compliance.

From Clinical Evaluation Report (CER) preparation to literature review and clinical data analysis, we help manufacturers develop MDR-compliant documentation that supports successful conformity assessments and European market access.

Book a Free 15-Minute Compliance Call
Get Clinical Evaluation Support

Expert EU MDR Clinical Evaluation Support for Medical Devices

Clinical evaluation is a mandatory requirement under EU MDR 2017/745 Article 61 for all medical devices seeking CE marking in Europe. It is a systematic and continuous process of collecting, appraising, and analyzing clinical data to demonstrate that a device is safe, performs as intended, and provides measurable clinical benefits to patients.

Under MDR, clinical evaluation applies to all device classes, from Class I to Class III, and must be maintained throughout the entire product lifecycle. Manufacturers are expected to generate and continuously update clinical evidence to support conformity with the General Safety and Performance Requirements (GSPRs).

Cert3Global provides structured EU MDR Clinical Evaluation Services to help manufacturers meet these requirements efficiently. We assist with clinical evaluation planning, evidence generation, literature review, data analysis, and documentation preparation to support CE marking and ongoing regulatory compliance.

What is EU MDR Clinical Evaluation?

EU MDR Clinical Evaluation is a planned and documented process used to collect, appraise, and analyze clinical data relating to a medical device. The objective is to verify that the device achieves its intended purpose, delivers the claimed clinical benefits, and does not present unacceptable risks to patients or users.

Under Article 61 and Annex XIV of MDR 2017/745, clinical evaluation is mandatory for all medical devices regardless of risk classification. The depth of clinical evidence required depends on factors such as device classification, intended use, novelty, and associated risks.

Clinical evaluation is not a one-time exercise. Manufacturers are required to maintain and update their clinical evaluation throughout the product lifecycle by incorporating new evidence generated from post-market surveillance activities, clinical investigations, published literature, and post-market clinical follow-up (PMCF).

When is Medical Device Clinical Evaluation Required?

Clinical evaluation is required for all medical devices placed on the European market. However, the extent and nature of clinical evidence vary depending on the device type and risk classification.

Class III and Implantable Devices

Clinical investigation data is generally required unless sufficient equivalence can be demonstrated and accepted during the conformity assessment process.

Class IIb Devices

Certain active devices may require additional scrutiny and may be subject to Clinical Evaluation Consultation Procedures (CECP).

Class IIa and Non-Implantable Class IIb Devices

A robust literature review and demonstration of equivalence may be sufficient to establish conformity in many cases.

Class I Devices

Clinical evaluation remains mandatory and documentation must be available for competent authorities upon request.

Novel Devices

Where equivalent products do not exist, clinical investigation data is generally necessary to demonstrate safety and performance.

EU MDR Clinical Evaluation Services You Can Rely On

Cert3Global provides practical and compliant EU MDR Clinical Evaluation Services to support manufacturers through every stage of evidence generation and documentation development.

Clinical Evaluation Planning

We assist in developing structured clinical evaluation strategies aligned with MDR Article 61 and Annex XIV requirements.

Literature Review & Clinical Data Identification

We support the identification, collection, and appraisal of relevant clinical evidence from scientific literature, equivalent devices, and post-market data sources.

Clinical Data Analysis

Our experts evaluate clinical evidence to assess device safety, performance, and benefit-risk profiles.

Clinical Evaluation Report (CER) Preparation

We prepare and review Clinical Evaluation Reports that align with MDR requirements and support technical documentation and CE marking applications.

Clinical Evidence Gap Assessment

We identify gaps in existing clinical documentation and recommend appropriate remediation strategies to support compliance.

CER Updates & Lifecycle Support

We assist manufacturers with periodic updates to Clinical Evaluation Reports and integration of post-market clinical evidence throughout the device lifecycle.

The services above are directly aligned with the activities described under MDR Article 61 and Annex XIV, including planning, evaluating, and documenting clinical evidence necessary for CE marking and ongoing compliance.

Why is EU MDR Clinical Evaluation Important?

Clinical evaluation is a fundamental component of medical device technical documentation and one of the key requirements for obtaining and maintaining CE marking under MDR.

A properly executed clinical evaluation:
  • Demonstrates device safety and clinical performance
  • Supports conformity with General Safety and Performance Requirements (GSPRs)
  • Provides scientific evidence for benefit-risk determination
  • Supports Notified Body review and conformity assessment
  • Reduces the likelihood of major non-conformities during audits
  • Enables continuous monitoring of device performance throughout its lifecycle
As MDR requirements have become significantly more stringent than the previous Medical Device Directive (MDD), manufacturers need robust and continuously maintained clinical evidence to support compliance.
Contact Us

Essential Clinical Evaluation Documentation

Clinical evaluation documentation forms a critical part of the technical documentation submitted during MDR conformity assessment. The documentation should clearly demonstrate the safety, performance, and clinical benefits of the device through objective and scientifically justified evidence.
Typical clinical evaluation documentation may include:
  • Clinical Evaluation Plan (CEP)
  • Clinical Evaluation Report (CER)
  • Literature Search Protocol and Results
  • Clinical Data Appraisal and Analysis
  • Benefit-Risk Evaluation
  • Post-Market Surveillance (PMS) Data
  • Post-Market Clinical Follow-Up (PMCF) Information
  • Equivalence Justification (where applicable)
Maintaining accurate and well-organized clinical documentation is essential for successful technical file review and long-term regulatory compliance.

Why Choose Cert3Global?

Cert3Global provides reliable EU MDR Clinical Evaluation Services designed to help medical device manufacturers build strong clinical evidence and maintain compliance with MDR requirements.
We offer:
  • End-to-end clinical evaluation support
  • MDR Article 61 and Annex XIV expertise
  • Clinical Evaluation Report (CER) preparation and review
  • Literature review and clinical data analysis
  • Gap assessments and remediation strategies
  • Ongoing lifecycle documentation support
Our approach focuses on practical regulatory guidance, accurate documentation, and long-term compliance support to help manufacturers navigate MDR requirements with confidence.

Start Your EU MDR Clinical Evaluation Process

Developing MDR-compliant clinical evidence requires a systematic approach, robust documentation, and regulatory expertise. Cert3Global supports medical device manufacturers through every stage of clinical evaluation, helping ensure that your device meets European requirements for safety, performance, and clinical benefit.

Book a Free 15-Minute Compliance Call

FAQs

What is EU MDR Clinical Evaluation?

EU MDR Clinical Evaluation is a systematic process of collecting, evaluating, and analyzing clinical data to demonstrate that a medical device is safe, performs as intended, and provides clinical benefits. It is mandatory under MDR Article 61.

Yes. Clinical evaluation is required for all device classes under MDR, including Class I devices. The level of evidence required depends on the device’s risk profile and intended use.
A Clinical Evaluation Report (CER) documents the conclusions of the clinical evaluation process and demonstrates conformity with applicable safety and performance requirements.
Clinical evaluation is a continuous process and must be updated throughout the device lifecycle based on new evidence from PMS activities, PMCF studies, design changes, or other relevant information.
Yes. Published literature, equivalent device data, clinical investigations, and post-market information may all contribute to the clinical evidence used during the clinical evaluation process.

Disclaimer

Cert3Global provides regulatory consulting and UK Responsible Person services for cosmetics. Compliance outcomes and market access remain subject to applicable UK cosmetic regulations.